Ranibizumab is not bevacizumab for retinal vein occlusions

被引：0
作者：
Roberto Gallego-Pinazo
Rosa Dolz-Marco
Manuel Díaz-Llopis
机构：
[1] University and Polytechnic Hospital La Fe,Unit of Macula. Department of Ophthalmology
[2] University of Valencia,Faculty of Medicine
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2012年 / 250卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：955 / 956
页数：1
相关论文
共 32 条
  • [1] Brown DM(2011)Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 1594-1602
  • [2] Campochiaro PA(2011)Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab Eye (Lond) 25 661-672
  • [3] Bhisitkul RB(2007)Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease Retina 27 426-431
  • [4] Ho AC(2011)Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion Retina 31 1075-1082
  • [5] Gray S(2011)Intravitreal bevacizumab for retinal vein occlusion and early growth of epiretinal membrane: a possible secondary effect? Br J Ophthalmol 95 391-395
  • [6] Saroj N(undefined)undefined undefined undefined undefined-undefined
  • [7] Adamis AP(undefined)undefined undefined undefined undefined-undefined
  • [8] Rubio RG(undefined)undefined undefined undefined undefined-undefined
  • [9] Murahashi WY(undefined)undefined undefined undefined undefined-undefined
  • [10] Meyer CH(undefined)undefined undefined undefined undefined-undefined
1234